Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Document Type,Source,EID
"Lauriello, J., Lambert, T., Andersen, S., Lin, D., Taylor, C.C., McDonnell, D.","An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia",2008,"Journal of Clinical Psychiatry","69","5",,"790","799",,93,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-45249085941&partnerID=40&md5=9d8def08c0fbe2387a5fff4c2910e90f",Article,Scopus,2-s2.0-45249085941
"Mamo, D., Kapur, S., Keshavan, M., Laruelle, M., Taylor, C.C., Kothare, P.A., Barsoum, P., McDonnell, D.","D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: An open-label study in patients with schizophrenia",2008,"Neuropsychopharmacology","33","2",,"298","304",,50,10.1038/sj.npp.1301409,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-36949008116&doi=10.1038%2fsj.npp.1301409&partnerID=40&md5=aa7d93ea1f6aab8320e8ff21a6f09af8",Article,Scopus,2-s2.0-36949008116
"Beasley Jr., C.M., Stauffer, V.L., Liu-Seifert, H., Taylor, C.C., Dunayevich, E., Davis, J.M.","All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: An integrated analysis",2007,"Journal of Clinical Psychopharmacology","27","3",,"252","258+E1-E6",,34,10.1097/JCP.0b013e3180582426,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-34248579125&doi=10.1097%2fJCP.0b013e3180582426&partnerID=40&md5=8b2259afee5fd04c424785c838028fe4",Article,Scopus,2-s2.0-34248579125
"Dunayevich, E., Sethuraman, G., Enerson, M., Taylor, C.C., Lin, D.","Characteristics of two alternative schizophrenia remission definitions: Relationship to clinical and quality of life outcomes",2006,"Schizophrenia Research","86","1-3",,"300","308",,34,10.1016/j.schres.2006.06.002,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747178942&doi=10.1016%2fj.schres.2006.06.002&partnerID=40&md5=3e2c31e16dada14e7b644264b370a8dd",Article,Scopus,2-s2.0-33747178942
"Hardy, T.A., Marquez, E., Kryzhanovskaya, L., Taylor, C.C., Cavazzoni, P.","Cross-sectional comparison of fasting lipids in normoglycemic patients with schizophrenia during chronic treatment with olanzapine, risperidone, or typical antipsychotics",2006,"Journal of Clinical Psychopharmacology","26","4",,"405","408",,16,10.1097/01.jcp.0000227705.56870.06,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746882758&doi=10.1097%2f01.jcp.0000227705.56870.06&partnerID=40&md5=049aad83eafcbd9a3aee6a49e8fad70a",Article,Scopus,2-s2.0-33746882758
"Mitchell, M., Riesenberg, R., Bari, M.A., Marquez, E., Kurtz, D., Falk, D., Hardy, T., Taylor, C.C., Mitchell, C.P., Cavazzoni, P.","A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects",2006,"Clinical Therapeutics","28","6",,"881","892",,21,10.1016/j.clinthera.2006.06.008,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745954788&doi=10.1016%2fj.clinthera.2006.06.008&partnerID=40&md5=6f0a1c5eb1c5b02c27b67feb200f5887",Article,Scopus,2-s2.0-33745954788
"Sethuraman, G., Taylor, C.C., Enerson, M., Dunayevich, E.","Response to Kujawa et al. letter-to-the-editor",2006,"Schizophrenia Research","84","1",,"172","173",,,10.1016/j.schres.2005.11.010,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646527792&doi=10.1016%2fj.schres.2005.11.010&partnerID=40&md5=a854f62c2f5d86a4b2d78060618aa44f",Letter,Scopus,2-s2.0-33646527792
"Beasley Jr., C.M., Sutton, V.K., Taylor, C.C., Sethuraman, G., Dossenbach, M., Naber, D.","Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment?",2006,"Journal of Clinical Psychopharmacology","26","1",,"40","44",,9,10.1097/01.jcp.0000195109.01898.5e,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-31544482658&doi=10.1097%2f01.jcp.0000195109.01898.5e&partnerID=40&md5=7f1e57cffde3a47030c003c1c70d9dd1",Article,Scopus,2-s2.0-31544482658
"Sethuraman, G., Taylor, C.C., Enerson, M., Dunayevich, E.","A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia",2005,"Schizophrenia Research","79","2-3",,"337","340",,33,10.1016/j.schres.2005.06.015,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-26844497355&doi=10.1016%2fj.schres.2005.06.015&partnerID=40&md5=8aac733c73d01d6e6a1d76b35dd7352a",Article,Scopus,2-s2.0-26844497355
"Bohlander, S., Grand, A., Kelsey, L., Miller, L.D., Herron-Rice, L., Taylor, C., Stevens, C.K., Friis, C.M.","Standards of professional performance and standards of practice for the gastroenterology and/or endoscopy setting.",2005,"Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.","28","5",,"422","427",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644828076&partnerID=40&md5=f639dab2f9f08fefe80bfbe0e3e634c2",Article,Scopus,2-s2.0-33644828076
"Beasley Jr., C.M., Sutton, V.K., Hamilton, S.H., Walker, D.J., Dossenbach, M., Taylor, C.C., Alaka, K.J., Bykowski, D., Tollefson, G.D.","A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic Relapse",2003,"Journal of Clinical Psychopharmacology","23","6",,"582","594",,66,10.1097/01.jcp.0000095348.32154.ec,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344033647&doi=10.1097%2f01.jcp.0000095348.32154.ec&partnerID=40&md5=830cb0df9fde5539361d81e941bcceed",Article,Scopus,2-s2.0-0344033647
"Wright, P., Lindborg, S.R., Birkett, M., Meehan, K., Jones, B., Alaka, K., Ferchland-Howe, I., Pickard, A., Taylor, C.C., Roth, J., Battaglia, J., Bitter, I., Chouinard, G., Morris, P.L.P., Breier, A.","Intramuscular Olanzapine and Intramuscular Haloperidol in Acute Schizophrenia: Antipsychotic Efficacy and Extrapyramidal Safety during the First 24 Hours of Treatment",2003,"Canadian Journal of Psychiatry","48","11",,"716","721",,40,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744226266&partnerID=40&md5=a7050317753de8c1b7c561738d16eb0c",Article,Scopus,2-s2.0-10744226266
"Lindborg, S.R., Beasley, C.M., Alaka, K., Taylor, C.C.","Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients",2003,"Psychiatry Research","119","1-2",,"113","123",,30,10.1016/S0165-1781(03)00107-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037628108&doi=10.1016%2fS0165-1781%2803%2900107-0&partnerID=40&md5=8d3d082d77c5de3723253b63031297aa",Article,Scopus,2-s2.0-0037628108
"Wright, P., Meehan, K., Birkett, M., Lindborg, S.R., Taylor, C.C., Morris, P., Breier, A.","A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy",2003,"Clinical Therapeutics","25","5",,"1420","1428",,47,10.1016/S0149-2918(03)80129-7,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037607491&doi=10.1016%2fS0149-2918%2803%2980129-7&partnerID=40&md5=2ba2d91762a192ab65b22e1ec8a7f360",Article,Scopus,2-s2.0-0037607491
"Chue, P., Jones, B., Taylor, C.C., Dickson, R.","Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia",2002,"Canadian Journal of Psychiatry","47","8",,"771","774",,32,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036810029&partnerID=40&md5=f3cf6497df7cfb25ef6c87699ec53ffc",Article,Scopus,2-s2.0-0036810029
"Breier, A., Meehan, K., Birkett, M., David, S., Ferchland, I., Sutton, V., Taylor, C.C., Palmer, R., Dossenbach, M., Kiesler, G., Brook, S., Wright, P.","A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia",2002,"Archives of General Psychiatry","59","5",,"441","448",,221,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036244492&partnerID=40&md5=79b059c131623743748bff098599fd1f",Article,Scopus,2-s2.0-0036244492
"Costa E Silva, J.A., Alvarez, N., Mazzotti, G., Gattaz, W.F., Ospina, J., Larach, V., Starkstein, S., Oliva, D., Cousins, L., Tohen, M., Taylor, C.C., Wang, J., Tran, P.V.","Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America",2001,"Journal of Clinical Psychopharmacology","21","4",,"375","381",,31,10.1097/00004714-200108000-00004,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034919926&doi=10.1097%2f00004714-200108000-00004&partnerID=40&md5=46e4b1d6fe7b21fb77fbf09a1b0284cb",Article,Scopus,2-s2.0-0034919926
"Basson, B.R., Kinon, B.J., Taylor, C.C., Szymanski, K.A., Gilmore, J.A., Tollefson, G.D.","Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone",2001,"Journal of Clinical Psychiatry","62","4",,"231","238",,224,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035024729&partnerID=40&md5=d3552a2ba8013c3a67e0d3d6bbee9181",Article,Scopus,2-s2.0-0035024729
"Tohen, M., Zhang, F., Taylor, C.C., Burns, P., Zarate, C., Sanger, T., Tollefson, G.","A meta-analysis of the use of typical antipsychotic agents in bipolar disorder",2001,"Journal of Affective Disorders","65","1",,"85","93",,54,10.1016/S0165-0327(00)00162-2,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035014149&doi=10.1016%2fS0165-0327%2800%2900162-2&partnerID=40&md5=1a4f5408195d7c86a5f4f6b54027f512",Article,Scopus,2-s2.0-0035014149
"Taylor, C., Schubert, M.L.","Decreased efficacy of polyethylene glycol lavage solution (Golytely) in the preparation of diabetic patients for outpatient colonoscopy: A prospective and blinded study",2001,"American Journal of Gastroenterology","96","3",,"710","714",,48,10.1016/S0002-9270(00)02403-5,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035071461&doi=10.1016%2fS0002-9270%2800%2902403-5&partnerID=40&md5=0e4f2bc0acd76d13d94ae08739268e8b",Article,Scopus,2-s2.0-0035071461
"Jones, B., Taylor, C.C., Meehan, K.","The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms",2001,"Journal of Clinical Psychiatry","62","SUPPL. 2",,"22","24",,43,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035127910&partnerID=40&md5=3daf3bf3b78b0439ccb8114a9c104b83",Article,Scopus,2-s2.0-0035127910
"Tollefson, G.D., Taylor, C.C.","Olanzapine: Preclinical and clinical profiles of a novel antipsychotic agent",2000,"CNS Drug Reviews","6","4",,"303","363",,7,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034440855&partnerID=40&md5=36bf9bd01cc2cd105261def973385b95",Review,Scopus,2-s2.0-0034440855
"David, S.R., Taylor, C.C., Kinon, B.J., Breier, A.","The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia",2000,"Clinical Therapeutics","22","9",,"1085","1096",,192,10.1016/S0149-2918(00)80086-7,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033815409&doi=10.1016%2fS0149-2918%2800%2980086-7&partnerID=40&md5=6961d92ae89bc1e3e061f7ab42db675b",Article,Scopus,2-s2.0-0033815409
"Brooke, D., Taylor, C., Gunn, J., Maden, A.","Substance misuse as a marker of vulnerability among male prisoners on remand",2000,"British Journal of Psychiatry","177","SEPT",,"248","251",,27,10.1192/bjp.177.3.248,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033830385&doi=10.1192%2fbjp.177.3.248&partnerID=40&md5=beb8a55889b80b0e582a20988a01bd52",Article,Scopus,2-s2.0-0033830385
"Taylor, C.C., Wu, D., Soong, Y.I., Yee, J.S., Szeto, H.H.","Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: The role of receptor subtypes and route of administration",1997,"Journal of Pharmacology and Experimental Therapeutics","281","1",,"129","135",,6,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030995374&partnerID=40&md5=1cac3c4a48f5f3335b3b74d9d2199119",Article,Scopus,2-s2.0-0030995374
"Taylor, C.C., Soong, Y.I., Wu, D., Yee, J.S., Szeto, H.H.","Morphine stimulates adrenocorticotropin and cortisol release in the late-term ovine fetus",1997,"Pediatric Research","41","3",,"411","415",,8,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031020534&partnerID=40&md5=e8f1837f254a4720e927c04ae0fb6a10",Article,Scopus,2-s2.0-0031020534
"Taylor, C.C., Wu, D., Soong, Y., Yee, J.S., Szeto, H.H.","Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism",1997,"Journal of Pharmacology and Experimental Therapeutics","280","1",,"416","421",,12,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030614435&partnerID=40&md5=51bd6ea46a6e2f737a3f90b4e4d41b12",Article,Scopus,2-s2.0-0030614435
"Johnson, C.L., Taylor, C.","Working with difficult-to-treat eating disorders using an integration of twelve-step and traditional psychotherapies",1996,"Psychiatric Clinics of North America","19","4",,"829","841",,9,10.1016/S0193-953X(05)70384-1,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029840860&doi=10.1016%2fS0193-953X%2805%2970384-1&partnerID=40&md5=8e4d054f19a464b0bba38ad3c2c425a9",Review,Scopus,2-s2.0-0029840860
"Taylor, C.C., Wu, D., Soong, Y.I., Yee, J.S., Szeto, H.H.","κ-opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor",1996,"Journal of Pharmacology and Experimental Therapeutics","277","2",,"877","884",,15,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030424475&partnerID=40&md5=bbfe6b3466713a2aada2b9a183893413",Article,Scopus,2-s2.0-0030424475
"Szeto, H.H., Wu, D., Cheng, P.Y., Soong, Y., Taylor, C.C., Yee, J.","Cardiovascular and respiratory actions of U50,488H in the unanaesthetized ovine foetus",1996,"European Journal of Pharmacology","297","1-2",,"77","82",,6,10.1016/0014-2999(95)00726-1,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030041806&doi=10.1016%2f0014-2999%2895%2900726-1&partnerID=40&md5=155eaf70eaf3f5ba8c0c9cab12ad784e",Article,Scopus,2-s2.0-0030041806
"Taylor, C.C., Wu, D., Soong, Y., Yee, J.S., Szeto, H.H.","Differential mechanisms of ovine fetal pituitary stimulation by a selective κ-opioid agonist and by dynorphin",1996,"Neuroendocrinology","64","6",,"419","424",,6,10.1159/000127147,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030443967&doi=10.1159%2f000127147&partnerID=40&md5=7b31b140f6ad2f32df84bb8c005194cb",Article,Scopus,2-s2.0-0030443967
"Taylor, C.C., Soong, Y., Wu, D.L., Szeto, H.H.","Differential effects of μ, δ and κ opioid agonists on fetal plasma cortisol levels.",1994,"Regulatory Peptides","54","1",,"297","298",,2,10.1016/0167-0115(94)90507-X,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028135671&doi=10.1016%2f0167-0115%2894%2990507-X&partnerID=40&md5=971fb6d70f63cff327f7529aa7f5fe40",Article,Scopus,2-s2.0-0028135671
"Taylor, C.","Managing the manipulative therapist [3]",1994,"British Journal of Psychiatry","164","MAY",,"698","699",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028216612&partnerID=40&md5=bc896d5dc1e2188b012b2650ad9541ef",Letter,Scopus,2-s2.0-0028216612
"Taylor, C.C.","Letter: Chemical toxicity and mental disorder.",1974,"American Journal of Psychiatry","131","5",,"609","",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0016062779&partnerID=40&md5=f79f707dd8999bb4a93495e6fcfd0df0",Article,Scopus,2-s2.0-0016062779
